News
Topics
2019
-
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
-
Implementing the Group’s Social Contribution Activity: “Sysmex Gives Back Day”
-
Business Results Announcement for the Fiscal Year Ending March 31, 2020 (See Latest Financial Statements)
-
Updated : Sysmex Report 2019
-
Development of a Fully Automated Measurement Method for Soluble Immune Checkpoint Molecules (sPD-1, sPD-L1 and sCTLA-4)
-
Updated : Sysmex Sustainability Data Book 2019
-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fourth Consecutive Year
-
Japan’s First Automated Hematology Analyzer Registered by the National Museum of Nature and Science as “Essential Historical Material for Science and Technology”
-
Sysmex Launches its Sample Preparation System PS-10 in North America, a New Product to Make Clinical Flow Cytometry Testing More Efficient
-
Implementing the “Sysmex Gives Back Challenge” to Promote Social Contribution Activities Consistently Throughout the Group(See 2019 CSR Topics)
-
Sysmex Obtains First Manufacturing and Marketing Approval in Japan for Blood-Based RAS Gene Mutation Testing for Colorectal Cancer
-
Business Results Announcement for the Fiscal Year Ending March 31, 2020 (See Latest Financial Statements)
-
Selected for Inclusion in the FTSE4 Good Index for 12 Consecutive Years
-
World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories
-
The OncoGuide™ NCC Oncopanel System Receives Insurance Coverage for Use in Cancer Genome Profiling
-
Sysmex Opens Technopark East Site, a Bio-Diagnostic Reagent Base
-
Contributing to the Early Detection and Treatment of Malaria through Standardized and More Efficient Malaria Testing